What is Cerovene?
Cerovene operates at the intersection of product development and manufacturing, with a core focus on Product Life Cycle Management. The company excels in developing and refining formulations to meet stringent regulatory approval standards, serving both retail partners and end customers. By leveraging proprietary technologies, Cerovene addresses complex formulation challenges, positioning itself as an innovator committed to maintaining relevance in a dynamic market. The company's expertise spans from initial concept to market-ready products, offering a comprehensive suite of services.
How much funding has Cerovene raised?
Cerovene has raised a total of $845K across 2 funding rounds:
Debt
$350K
Debt
$495K
Debt (2020): $350K with participation from PPP
Debt (2021): $495K led by PPP
What's next for Cerovene?
The recent major strategic investment signals a pivotal phase for Cerovene, likely enabling the company to scale its operations, enhance its proprietary technologies, and potentially expand its market reach. This enterprise-level backing suggests a strategic focus on accelerating product development cycles and strengthening its position in the competitive product development and manufacturing sector. Cerovene is poised to capitalize on this momentum, driving further advancements in formulation science and manufacturing efficiency.
See full Cerovene company page
